TransCode Therapeutics, Inc.
RNAZ
$1.78
-$0.11-5.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.68% | 10.95% | 206.54% | 51.18% | 119.84% |
| Total Receivables | -99.66% | -99.81% | -- | 1,552.50% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.29% | 13.46% | -7.10% | -10.05% | -7.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 260.58% | 290.05% | 208.44% | 3.78% | -35.74% |
| Total Current Assets | 29.14% | 28.40% | 209.92% | 31.51% | 87.89% |
|
|
|||||
| Total Current Assets | 29.14% | 28.40% | 209.92% | 31.51% | 87.89% |
| Net Property, Plant & Equipment | 1,206.88% | 809.97% | 315.12% | -90.60% | -92.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -77.66% | -- | 307.24% | -- |
| Total Assets | 1,726.79% | 1,091.15% | 2,126.32% | 32.79% | 71.34% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 199.19% | 110.91% | 29.03% | 39.24% | -52.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 244.96% | 114.31% | 26.06% | 29.94% | -55.32% |
|
|
|||||
| Total Current Liabilities | 244.96% | 114.31% | 26.06% | 29.94% | -55.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,209.95% | 1,753.34% | 7.39% | -- | -- |
| Total Liabilities | 497.15% | 335.73% | 12.94% | 66.41% | -39.51% |
|
|
|||||
| Common Stock & APIC | 10.49% | 36.60% | 76.84% | 45.73% | 52.36% |
| Retained Earnings | -53.84% | -53.61% | -54.84% | -47.44% | -44.84% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -550.49% | -87.84% | 611.99% | -13.69% | 364.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -550.49% | -87.84% | 611.99% | -13.69% | 364.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2,150.57% | 1,304.11% | 7,623.65% | -13.69% | 364.92% |
|
|
|||||